Study: Migraine shot cuts headache days by half for 70% of older patients after a year
"Mom, another headache. Go to the hospital and try the shot. " "Is it OK for someone my age to get such an expensive injection.
Search results for "diabetes treatment"
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients
Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage. Patients with refractory—or treatment-resistant—Crohn’s...
Why Cutting Carbs Isn’t Enough: The Critical Link Between Circadian Stability and Glycemic Success
For individuals living with diabetes, dietary choices are traditionally considered the most critical factor in health...
The GLP-1 Paradox: Wegovy and Mounjaro Patients Shed Weight, but Walk Less
"First I’ll lose the weight, and then I’ll start exercising."It is a thought shared by almost anyone starting highly...
Prostate Cancer Now Ranks No. 1 Among Men in South Korea, Yet National Screening Still Excludes Critical PSA Test
Prostate cancer has emerged as the most frequently diagnosed cancer among men in South Korea.
New Hope for MASH: Researchers Uncover Key to Reversing Liver Fibrosis
Researchers have unveiled findings that raise hopes for a future where a single pill could safely and effectively treat...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial
HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
Why Uncontrolled Blood Sugar Spikes Raise the Risk of Pancreatic Cancer
Public interest in the pancreas has been on the rise lately, with more people searching for terms like "pancreatic...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...